Legend Biotech Corporation header image

Legend Biotech Corporation

LEGN

Equity

ISIN null / Valor 54834759

NASDAQ (2026-03-27)
USD 16.80-3.95%

Legend Biotech Corporation
UMushroom community rating:

star star star star star
4.00 11 votes No rating yet
NegativeNeutralPositive

About company

Legend Biotech Corporation is a biotechnology company focused on developing investigational agents and innovative technologies in personalized medicine, with a particular emphasis on cell therapies for treating hematological malignancies and solid tumors. The company is dedicated to exploring the potential of cell therapies to address diseases that are considered intractable and incurable. Through its pipeline of cutting-edge therapies, Legend Biotech aims to provide new treatment options for patients with challenging medical conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-52.5%1Y
-64.2%3Y
-40.0%5Y

Performance

48.3%1Y
46.6%3Y
51.7%5Y

Volatility

Market cap

3107 M

Market cap (USD)

Daily traded volume (Shares)

1,307,503

Daily traded volume (Shares)

1 day high/low

32.9 / 32.18

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

11 votes
Performance:
starstarstarstarstar
4.03
Innovation:
starstarstarstarstar
4.31
Society:
starstarstarstarstar
4.13
Nature:
starstarstarstarstar
4.09
Thomas Yarwood
United Kingdom, 09 Mar 2026
star star star star star
Growth potential
Thomas Yarwood
United Kingdom, 25 Feb 2026
star star star star star
Growth potential
ola ho
United Kingdom, 22 Feb 2026
star star star star star
n/a

EQUITIES OF THE SAME SECTOR

Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc Ionis Pharmaceuticals Inc Valor: 30877188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.82%USD 72.15
Intra-Cellular Therapies Inc
Intra-Cellular Therapies Inc Intra-Cellular Therapies Inc Valor: 23194616
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 131.87
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.98%USD 18.16
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc GE Healthcare Technologies Inc Valor: 123735674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.23%USD 69.23
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.73%USD 27.27
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.56%EUR 26.00
Guardant Health Inc
Guardant Health Inc Guardant Health Inc Valor: 43633454
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.96%USD 84.61
Laboratorios Farmaceuticos Rovi, SA
Laboratorios Farmaceuticos Rovi, SA Laboratorios Farmaceuticos Rovi, SA Valor: 3591807
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%EUR 78.90
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.10%CHF 312.50
Align Technology Inc
Align Technology Inc Align Technology Inc Valor: 1159441
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.17%USD 166.38